Oncology PracticeNew injectable gel can deliver immune cells directly to cancer tumorsApril 15, 2022ImmunotherapyImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeAdverse skin effects of cancer immunotherapy reviewedMarch 21, 2022MelanomaImmunotherapyLung CancerMixed Topics
Oncology PracticeWomen at higher risk of serious adverse events from cancer therapyFebruary 17, 2022Patient & Survivor CareGastrointestinal CancerLung CancerLeukemia, Myelodysplasia, TransplantationImmunotherapyCLL
Oncology PracticeReview eyes nail unit toxicities secondary to targeted cancer therapyAugust 24, 2021Immunotherapy
Oncology PracticeHyperprogression on immunotherapy: When outcomes are much worseApril 30, 2021ImmunotherapyNonmelanoma Skin CancerMelanomaBreast CancerGastroenterologyGastrointestinal CancerGenitourinary Cancer
Oncology PracticeFDA panel votes against 2 cancer indications but backs 4 of 6April 30, 2021ImmunotherapyBreast CancerGenitourinary CancerGastrointestinal CancerPatient & Survivor CareMetastatic Breast Cancer
Oncology PracticeTo stay: Two more cancer indications with ‘dangling approvals’April 29, 2021Genitourinary CancerImmunotherapy
Hematology NewsAllo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALLMarch 24, 2021TransplantALLLeukemia, Myelodysplasia, TransplantationImmunotherapy
Oncology PracticeCheckpoint inhibitor–induced rheumatic complications often arise lateMarch 15, 2021Immunotherapy
Oncology PracticeCheckpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021ImmunotherapyMelanomaGastroenterologyGastrointestinal Cancer
Oncology PracticeHow should we evaluate the benefit of immunotherapy combinations?December 10, 2020ImmunotherapyLung CancerMelanomaPatient & Survivor Care
Oncology PracticeImmune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggestNovember 25, 2020Patient & Survivor CareCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerImmunotherapyLeukemia, Myelodysplasia, Transplantation
Oncology PracticeReal-world results with checkpoint inhibitors found inferior to trial resultsOctober 30, 2020ImmunotherapyLung CancerMelanomaHead & Neck/Thyroid CancersGenitourinary CancerGastroenterologyRenal Cell Carcinoma
Oncology PracticeLower BP and better tumor control with drug combo?October 26, 2020ImmunotherapyLung CancerBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastroenterology
Oncology PracticeLenvatinib combo may offer hope after immunotherapy in melanomaSeptember 23, 2020MelanomaImmunotherapy
